fluphenazine has been researched along with Depressive Disorder in 39 studies
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
Excerpt | Relevance | Reference |
---|---|---|
"Neuropeptide Y (a recently discovered brain peptide that is colocalized with norepinephrine within some adrenergic central nervous system neurons) was measured in the cerebrospinal fluid (CSF) from patients with major affective disorder, chronic schizophrenia, and in normal volunteers." | 7.67 | Cerebrospinal fluid neuropeptide Y in depression and schizophrenia. ( Berrettini, WH; Doran, AR; Kelsoe, J; Pickar, D; Roy, A, 1987) |
" All patients had been diagnosed as having schizophrenia or schizoaffective disorder, all were receiving stable doses of fluphenazine decanoate, and all had received benztropine mesylate in an attempt to rule out neuroleptic-induced akinesia." | 5.06 | Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. ( Cooper, TB; Fagerstrom, R; Morgan, V; Rifkin, A; Siris, SG, 1987) |
"Neuropeptide Y (a recently discovered brain peptide that is colocalized with norepinephrine within some adrenergic central nervous system neurons) was measured in the cerebrospinal fluid (CSF) from patients with major affective disorder, chronic schizophrenia, and in normal volunteers." | 3.67 | Cerebrospinal fluid neuropeptide Y in depression and schizophrenia. ( Berrettini, WH; Doran, AR; Kelsoe, J; Pickar, D; Roy, A, 1987) |
"The authors present four patients with Gilbert's Syndrome and concurrent psychiatric illness." | 1.29 | Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome) and concurrent psychotropic drug administration. ( Dorevitch, A; Durst, R; Jabotinsky-Rubin, K; Kikinzon, L; Tur-Kaspa, R, 1993) |
"Two cases of agranulocytosis occurring after addition of a butyrophenone to a course of phenothiazine treatment are reported and possible mechanisms for this interaction are discussed." | 1.28 | Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment. ( Kehoe, R; Young, A, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (71.79) | 18.7374 |
1990's | 9 (23.08) | 18.2507 |
2000's | 1 (2.56) | 29.6817 |
2010's | 1 (2.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Preskorn, SH | 1 |
CAMBA, ME | 1 |
PARDO, RF | 1 |
GANDARALAMAS, M | 1 |
ABOAB, R | 1 |
Dunlop, BW | 1 |
Sternberg, M | 1 |
Phillips, LS | 1 |
Andersen, J | 1 |
Duncan, E | 1 |
Mandel, MR | 1 |
Severe, JB | 1 |
Schooler, NR | 2 |
Gelenberg, AJ | 1 |
Mieske, M | 1 |
Hogan, TP | 1 |
Awad, AG | 1 |
Siris, SG | 10 |
Rifkin, A | 3 |
Reardon, GT | 2 |
November, M | 1 |
Kane, JM | 1 |
Garbutt, JC | 1 |
Loosen, PT | 1 |
Wistedt, B | 1 |
Palmstierna, T | 1 |
Valle-Jones, JC | 2 |
Craven, JR | 1 |
Wallis, TD | 1 |
Schiff, AA | 2 |
Johnson, DA | 3 |
Mauri, MC | 1 |
Bravin, S | 1 |
Mantero, M | 1 |
Invernizzi, G | 1 |
Hogarty, GE | 1 |
McEvoy, JP | 1 |
Ulrich, RF | 1 |
DiBarry, AL | 1 |
Bartone, P | 1 |
Cooley, S | 1 |
Hammill, K | 1 |
Carter, M | 1 |
Munetz, MR | 1 |
Perel, J | 1 |
Bermanzohn, PC | 1 |
Mason, SE | 2 |
Shuwall, MA | 1 |
Steingard, S | 1 |
Allen, M | 1 |
Durst, R | 2 |
Jabotinsky-Rubin, K | 1 |
Dorevitch, A | 1 |
Kikinzon, L | 1 |
Tur-Kaspa, R | 1 |
Schramm, M | 1 |
Falkai, P | 1 |
Feldmann, N | 1 |
Knable, MB | 1 |
Bayer, TA | 1 |
Sinclair, JM | 1 |
Walsh, MR | 1 |
Signer, SF | 1 |
Weinstein, RP | 1 |
Munoz, RA | 1 |
Bayardo, JF | 1 |
Katz, MR | 1 |
Saben, LR | 1 |
Robinson, S | 1 |
Rosca, P | 1 |
Shai, U | 1 |
Ghinea, C | 1 |
Schmidt, U | 1 |
Nir, I | 1 |
Gingerich, S | 2 |
Breier, A | 1 |
Young, A | 1 |
Kehoe, R | 1 |
Hirsch, SR | 2 |
Jolley, AG | 1 |
Adan, F | 3 |
Cutler, J | 1 |
Owen, K | 1 |
Mason, S | 1 |
Lang, MP | 1 |
Galdi, J | 1 |
Bonato, RR | 1 |
Cohen, M | 1 |
Mandeli, J | 2 |
Aronson, A | 1 |
Casey, E | 2 |
Strahan, A | 2 |
Lee, A | 1 |
Cooper, TB | 2 |
Berrettini, WH | 1 |
Doran, AR | 1 |
Kelsoe, J | 1 |
Roy, A | 1 |
Pickar, D | 1 |
Morgan, V | 1 |
Fagerstrom, R | 1 |
Blum, A | 1 |
Curson, DA | 1 |
Barnes, TR | 1 |
Bamber, RW | 1 |
Platt, SD | 1 |
Duffy, JC | 1 |
Hinterhuber, H | 1 |
Neumann, R | 1 |
Doddi, SR | 1 |
Hall, KS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia[NCT00595504] | Phase 4 | 25 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia[NCT03075657] | Phase 4 | 120 participants (Actual) | Interventional | 2017-05-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
A comparison between the ramelteon group and the placebo group of change in abdominal fat measured by a DEXA scan, assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
Intervention | g (Mean) |
---|---|
Ramelteon | 3934.86 |
Placebo (Sugar Pill) | 5120.92 |
A comparison between the ramelteon group and the placebo group of change in insulin resistance measured by the homeostatic model assessment of insulin resistance (HOMA-IR), assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
Intervention | HOMA score (Mean) |
---|---|
Ramelteon | 2.4 |
Placebo (Sugar Pill) | 2.36 |
A comparison between the ramelteon group and the placebo group in change in waist circumference (measured in cm) measured at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
Intervention | cm (Mean) |
---|---|
Ramelteon | 106.09 |
Placebo (Sugar Pill) | 108.37 |
3 reviews available for fluphenazine and Depressive Disorder
Article | Year |
---|---|
CNS drug development. Part I: The early period of CNS drugs.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Central | 2010 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Sche | 1984 |
Antipsychotic medication: clinical guidelines for maintenance therapy.
Topics: Administration, Oral; Ambulatory Care; Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Dise | 1985 |
17 trials available for fluphenazine and Depressive Disorder
Article | Year |
---|---|
Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind | 1982 |
Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
Topics: Adult; Benztropine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy | 1983 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Sche | 1984 |
A dramatic behavioral response to thyrotropin-releasing hormone following low-dose neuroleptics.
Topics: Adult; Borderline Personality Disorder; Clinical Trials as Topic; Depressive Disorder; Double-Blind | 1984 |
Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Male; P | 1983 |
Mixed anxiety/depressive illness in general practice. A therapeutic comparison of nomifensine with fluphenazine/nortriptyline.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Drug Combinati | 1983 |
Studies of depressive symptoms in schizophrenia.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; | 1981 |
Pharmacotherapy of impaired affect in recovering schizophrenic patients.
Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Anxiety Disorders; Basal Ganglia Diseases; | 1995 |
Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
Topics: Adult; Antipsychotic Agents; Benztropine; Delayed-Action Preparations; Depressive Disorder; Double-B | 1994 |
A study of the pharmacologic treatment of medication-compliant schizophrenics who relapse.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Fe | 1994 |
Treatment of anxiety/depressive conditions in the elderly: a double-blind comparative study of Motival and amitriptyline.
Topics: Aged; Amitriptyline; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Double-Blind | 1975 |
A.E. Bennett award paper. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients.
Topics: Adrenocorticotropic Hormone; Adult; Arousal; beta-Endorphin; Blood Glucose; Clinical Trials as Topic | 1989 |
The dysphoric syndrome in schizophrenia and its implications for relapse.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluphenazine; Fol | 1989 |
Relationship of adverse drug reactions to length of hospital-stay in genetically subgrouped schizophrenics.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1988 |
Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
Topics: Adolescent; Adult; Aged; Benztropine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1988 |
Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination | 1987 |
Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. II. The incidence of compliance problems, side-effects, neurotic symptoms and depression.
Topics: Clinical Trials as Topic; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Dys | 1985 |
20 other studies available for fluphenazine and Depressive Disorder
Article | Year |
---|---|
[FLUPHENAZINE DIHYDROCHLORIDE].
Topics: Achlorhydria; Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Dyspepsia; Feeding and Ea | 1964 |
[FLUPHANAZINE IN TENSION AND DEPRESSION].
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Fluphenazine; Humans; Mental Disorders; | 1963 |
Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Cohort Studies; Depressive Disorder; Diabetes | 2003 |
Pharmacotherapy and suicide risk in schizophrenia.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluphenazine; H | 1983 |
Depression in schizophrenia: clinical and pharmacological variables.
Topics: Adolescent; Adult; Age Factors; Aged; Depressive Disorder; Dexamethasone; Female; Fluphenazine; Halo | 1995 |
Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome) and concurrent psychotropic drug administration.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Fluphenazine; Gilbert Disease; | 1993 |
Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Cerebellum; Depressive Disorder; Female; Fluphe | 1998 |
Pseudocyesis in organic mood disorders. Six cases.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Delusions; Depressive Disorder; Diagnosis, | 1992 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Patients' and caregivers' adaptation to improvement in schizophrenia.
Topics: Adult; Assertiveness; Depressive Disorder; Drug Therapy, Combination; Family; Female; Fluphenazine; | 1990 |
Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment.
Topics: Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Clomipramine; Depressive Disorder; Dose-Respo | 1989 |
Trials of adjunctive alprazolam in "negative symptom" patients.
Topics: Adult; Alprazolam; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Hallucinations; Hum | 1989 |
Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
Topics: Adult; Benztropine; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Fluphenazin | 1989 |
The significance of depression in the prediction of relapse in chronic schizophrenia.
Topics: Adult; Depressive Disorder; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Recurrenc | 1988 |
Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
Topics: Benztropine; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Humans; Imipramine; Psych | 1988 |
Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Topics: Adult; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug T | 1988 |
Cerebrospinal fluid neuropeptide Y in depression and schizophrenia.
Topics: Biomarkers; Depressive Disorder; Female; Fluphenazine; Humans; Male; Neuropeptide Y; Reference Value | 1987 |
Is postpsychotic depression a primary affective disorder?
Topics: Depressive Disorder; Fluphenazine; Humans; Psychotic Disorders; Schizophrenia | 1986 |
[Depressive syndromes within the scope of schizophrenic psychoses].
Topics: Depressive Disorder; Fluphenazine; Hallucinations; Humans; Long-Term Care; Male; Models, Psychologic | 1985 |
Stability of the postpsychotic depression syndrome.
Topics: Adult; Depressive Disorder; Female; Fluphenazine; Humans; Male; Middle Aged; Outcome and Process Ass | 1986 |